〔1〕Guarner J,Brandt ME. Histopathologic diagnosis of fungal
infections in the 21st century〔J〕. Clin Microbiol Rev,2011,
24(2):247-280.
〔2〕Bissek A, Tabah E, Kouotou E, et al.The spectrum of skin
diseases in a rural setting in Cameroon (sub-Saharan
Africa)〔J〕. BMC Dermatol, 2012,12:7-15.
〔3〕中华医学会皮肤病学分会援皮肤科就诊患者足病情况调
查〔J〕援中华皮肤科杂志,2000,33(1):55-56.
〔4〕Achterman RR, White TC. A foot in the door for
dermatophyte research〔J〕. PLoS Pathog, 2012,8(3),
e1002564.
〔5〕季文英. 浅部真菌病影响患者生活质量的调查分析〔J〕.
中国真菌学杂志, 2009, 4(3):148-150.
〔6〕Joish VN,Armstrong EP. Which antifungal agent for
onychomycosis:a pharmacoeconomic analysis〔J〕.
Pharmacoeconomics, 2001,19(10):983-1002.
〔7〕Ahmadinejad Z, Razaghi A, Noori A, et al. Prevalence of
fungal skin infections in Iranian Wrestlers〔J〕. Asian J
Sports Med,2013, 4(1):29-33.
〔8〕Low C, Rotstein C. Emerging fungal infections in
immunocompromised patients〔J〕. F1000 Med Rep,
2011,3:14, doi: 10.3410/M3-14.
〔9〕李波,甘春葆. 某学院广东籍大学生足部真菌感染状况
〔J〕. 中国学校卫生,2006,27(10):907-908.
〔10〕马志红,章强强. 不同地区浅部真菌病病原菌流行状况
比较〔J〕. 中国真菌学杂志,2009,4(6):343-346.
〔11〕Jennings MB,Weinberg JM, Koestenblatt EK,et al.Study
of clinically suspected onychomycosis in a podiatric
population〔J〕. J Am Pndiatr Med Assoe, 2002, 92(6):
327-330. |